Medical suppression of hypercortisolemia in Cushing’s syndrome with particular consideration of etomidate

Severe hypercortisolism: A medical emergency requiring urgent intervention

(2010) Helen L. Lutgers et al.   CRITICAL CARE MEDICINE

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

(2010) Richard A. Feelders et al.   NEUROENDOCRINOLOGY

2 Diagnosis/differential diagnosis of Cushing's syndrome: a review of best practice

(2009) John Newell-Price   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Hypokalemia, Diabetes Mellitus, and Hypercortisolemia are the Major Contributing Factors to Cardiac Dysfunction in Adrenal Cushing’s Syndrome

(2009) Sachiko TAKAGI et al.   ENDOCRINE JOURNAL

Merits and pitfalls of mifepristone in Cushing's syndrome

(2009) F Castinetti et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Drugs in the medical treatment of Cushing's syndrome

(2009) David E Schteingart   EXPERT OPINION ON EMERGING DRUGS

Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas

(2009) Christiaan de Bruin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A novel use of etomidate for intentional adrenal suppression to control severe hypercortisolemia in childhood*

(2009) Nicole Mettauer et al.   Pediatric Critical Care Medicine

Etomidate Infusion in the Critical Care Setting for Suppressing the Acute Phase of Cushing’s Syndrome

(2008) Ali Dabbagh et al.   ANESTHESIA AND ANALGESIA

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

(2008) Lynnette K. Nieman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Surgery for Cushing’s Syndrome: An Historical Review and Recent Ten-year Experience

(2008) John R. Porterfield et al.   WORLD JOURNAL OF SURGERY